Search results for "SUPPRESSION"

showing 10 items of 404 documents

HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy

2005

In hepatitis B virus (HBV) cirrhosis patients on long-term lamivudine (LAM), the relationships between HBV suppression, development of viral resistance and disease outcome are unclear. We analysed the dynamic of serum HBV-DNA and its relationship with the clinical course of 59 patients (52 males, mean age 51.4 ±8.4 years, 12 HBeAg positive and 47 HBeAg negative, and 57 genotype D and two genotype A) with cirrhosis (45 in Child-Turcotte-Pugh class A) and high levels of serum HBV-DNA (median 14.7x107 genomes/ml) treated with LAM [median (range): 44 (15–78) months]. A total of 50 patients (84.7%) achieved a virological response (serum HBV-DNA negative by PCR) during the first 6 months of ther…

AdultLiver CirrhosisMaleHepatitis B virusCirrhosisHBV DNA Lamivudine Therapy suppression HBV diseasemedicine.disease_causeVirus ReplicationAntiviral AgentsVirusDrug Administration ScheduleDisease courseCohort StudiesOrthohepadnavirusmedicineHumansPharmacology (medical)AgedPharmacologyHepatitis B virusbiologyReverse-transcriptase inhibitorLamivudineMiddle Agedbiology.organism_classificationmedicine.diseaseHepatitis BVirologydigestive system diseasesInfectious DiseasesHepadnaviridaeLamivudineDNA ViralMutationFemalemedicine.drug
researchProduct

Hematological immune related adverse events after treatment with immune checkpoint inhibitors

2021

Abstract Introduction With the increasing use of checkpoint inhibitors, rare immune-related adverse events (irAE) are being identified. Haematological irAE (hem-irAE) are difficult to treat and have shown high mortality rates. In order to improve side-effect management for these potentially life-threatening events, we analysed frequency, severity and outcomes. Patients and methods Patients who developed hem-irAE while being treated with immune checkpoint inhibitors (ICI) therapy were retrospectively identified from 18 international cancer centres. Results In total, more than 7626 patients treated with ICI were screened, and 50 patients with hem-irAE identified. The calculated incidence amou…

AdultMale0301 basic medicineCancer Researchmedicine.medical_specialtyNeutropeniamedicine.medical_treatmentMedizinNeutropeniamedicine.disease_causeGastroenterologyAutoimmunityYoung Adult03 medical and health sciences0302 clinical medicineImmune systemAdrenal Cortex HormonesInternal medicinemedicineHumansAdverse effectImmune Checkpoint InhibitorsAgedRetrospective StudiesAged 80 and overHemophagocytic lymphohistiocytosisbusiness.industryIncidenceIncidence (epidemiology)CancerAnemiaImmunosuppressionMiddle Agedmedicine.diseaseThrombocytopeniaTreatment Outcome030104 developmental biologyOncology030220 oncology & carcinogenesisFemalebusinessImmunosuppressive Agents
researchProduct

Extended surgical safety margins and ulceration are associated with an improved prognosis in pleomorphic dermal sarcomas

2019

BACKGROUND Pleomorphic dermal sarcomas (PDS) are frequent UV-induced sarcomas of the skin of intermediate grade malignant potential. Despite the fact that PDS have a noteworthy potential to recur (up to 28%) as well as to metastasize (up to 20%), there are no specific clinical guidelines with respect to follow-up these patients. Moreover, little is known about clinical, histological or molecular prognostic factors in PDS. OBJECTIVE The aim of the present study was to identify risk factors to predict relapse in a large multicentre sample cohort of PDS which could aid to optimize personalized treatment recommendations regarding surgical safety margins and adjuvant radiotherapy. METHODS Patien…

AdultMale0301 basic medicineOncologymedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentDermatology03 medical and health sciences0302 clinical medicineInternal medicineStatistical significanceSurgical safetyHumansMedicineIntermediate GradeUlcerAgedAged 80 and overbusiness.industryProportional hazards modelHazard ratioMargins of Excisionfood and beveragesSarcomaImmunosuppressionMiddle AgedPrognosisConfidence interval030104 developmental biologyInfectious Diseases030220 oncology & carcinogenesisCohortFemalebusinessJournal of the European Academy of Dermatology and Venereology
researchProduct

An Assessment of the Effect of Human Herpesvirus-6 Replication on Active Cytomegalovirus Infection after Allogeneic Stem Cell Transplantation

2010

Human herpesvirus-6 (HHV-6) may enhance cytomegalovirus (CMV) replication in allogeneic stem cell transplant (allo-SCT) recipients either through direct or indirect mechanisms. Definitive evidence supporting this hypothesis are lacking. We investigated the effect of HHV-6 replication on active CMV infection in 68 allo-SCT recipients. Analysis of plasma HHV-6 and CMV DNAemia was performed by real-time PCR. Enumeration of pp65 and IE-1 CMV-specific IFNgamma CD8(+) and CD4(+)T cells was performed by intracellular cytokine staining. HHV-6 DNAemia occurred in 39.8% of patients, and was significantly associated with subsequent CMV DNAemia in univariate (P=.01), but not in multivariate analysis (P…

AdultMaleAdolescentInteractionHerpesvirus 6 Humanmedicine.medical_treatmentvirusesCongenital cytomegalovirus infectionRoseolovirus InfectionsVirus ReplicationYoung AdultHomologous chromosomemedicineHumansTransplantation HomologousCMV replicationAgedImmunosuppression TherapyTransplantationHuman herpesvirus 6 (HHV-6)biologybusiness.industryHematopoietic Stem Cell Transplantationvirus diseasesImmunosuppressionHematologyMiddle Agedmedicine.diseasebiology.organism_classificationAllo-SCT recipientVirologyCMV immune responseTransplantationViral replicationCytomegalovirus InfectionsDNA ViralImmunologyFemaleVirus ActivationHuman herpesvirus 6Stem cellCytomegalovirus (CMV)businessCD8Biology of Blood and Marrow Transplantation
researchProduct

Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.

1999

Abstract Background/Aims: Classification of autoimmune hepatitis (AIH) into different subgroups according to autoantibody status has been proposed: type I (ANA/SMA), type II (LKM-1) and type III (anti-SLA). However, whether type III AIH forms a clinically distinct disease entity remains controversial. The aim of this study was to evaluate the subclassification of AIH into ANA/SMA and anti-SLA positive patients with regard to clinical, biochemical and histologic differences. Methods: Ninety-seven consecutive patients with a well-documented long-term course of AIH with ANA/SMA and/or anti-SLA autoantibodies were studied. Clinical, biochemical and histological features of patients with ANA/SMA…

AdultMaleAnti-nuclear antibodyHLA-DR3Autoimmune hepatitisAutoantigensAutoimmune DiseasesHepatitisimmune system diseasesmedicineHumansClinical significanceAutoantibodiesAutoimmune diseaseHepatitisImmunosuppression TherapyHepatologybusiness.industryfungiAutoantibodyMuscle SmoothMiddle Agedmedicine.diseaseSMA*PrognosisAntibodies AntinuclearImmunologyFemalebusinessJournal of hepatology
researchProduct

The auditory N1 suppression rebounds as prediction persists over time

2016

International audience; The predictive coding model of perception proposes that neuronal responses reflect prediction errors. Repeated as well as predicted stimuli trigger suppressed neuronal responses because they are associated with reduced prediction errors. However, many predictable events in our environment are not isolated but sequential, yet there is little empirical evidence documenting how suppressed neuronal responses reflecting reduced prediction errors change in the course of a predictable sequence of events. Here we conceived an auditory electroencephalography (EEG) experiment where prediction persists over series of four tones to allow for the delineation of the dynamics of th…

AdultMaleAuditory perceptionTime FactorsCognitive Neurosciencemedia_common.quotation_subjectExperimental and Cognitive PsychologyNeuropsychological TestsElectroencephalographyevent-related potentialsta3112050105 experimental psychology03 medical and health sciencesBehavioral NeurosciencePrediction suppression0302 clinical medicineEvent-related potentialPerceptionmedicineHumans0501 psychology and cognitive sciencesPredictabilityta515media_commonPredictive codingCommunicationmedicine.diagnostic_testbusiness.industry[SCCO.NEUR]Cognitive science/Neuroscience05 social sciencesBrainElectroencephalographyMultiple factorsAcoustic StimulationAuditory N1Auditory PerceptionEvoked Potentials AuditoryFemaleprediction suppressionPsychologybusinessNeuroscience030217 neurology & neurosurgeryelectroencephalographyauditory N1Event-related potentials
researchProduct

HBV virological suppression: still not enough to save from hepatocellular carcinoma. A case report on a 15-year, real-life story

2017

Among HIV-infected patients worldwide, 2-4 million are chronically infected with HBV. We report a 15-year, real-life story of a patient with HBV-HIV coinfection, who developed HCC despite high treatment adherence and complete viral suppression. The aim of our report is to alert the infectious diseases community to monitor the possible development of HCC regardless of high treatment adherence and complete viral suppression.

AdultMaleCarcinoma HepatocellularCoinfectionMedicine (all)Liver NeoplasmsHIVVirological suppressionHIV InfectionsAntiviral AgentsMedication AdherenceHepatitis B ChronicHBVHumansHCCRecenti progressi in medicina
researchProduct

Transforming growth factor-β1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity

1998

Abstract Background/Aims: Transforming growth factor-β 1 (TGF-β 1 ) is considered the most important mediator of hepatic fibrogenesis. At the same time, TGF-β 1 is an immunosuppressive cytokine. Development of fibrosis, often rapid, is a characteristic of autoimmune hepatitis, as is spontaneous systemic immunosuppression. The aim of our study was therefore to define the role of TGF-β 1 in autoimmune hepatitis. Methods/Results: Using the MV 1Lu bioassay, we found markedly elevated serum levels of TGF-β 1 (median 109 ng/ml) in active autoimmune hepatitis, which normalised when patients reached biochemical remission following immunosuppressive therapy (median 34 ng/ml; p =0.0001 compared to ac…

AdultMaleCirrhosisAdolescentmedicine.medical_treatmentInflammationAutoimmune hepatitismedicine.disease_causeMonocytesAutoimmunityTransforming Growth Factor betaFibrosisHumansMedicineIn Situ HybridizationAgedInflammationHepatitisHepatologybusiness.industryImmunosuppressionMiddle Agedmedicine.diseaseImmunohistochemistryHepatitis AutoimmuneCytokineLiverImmunologyBiological AssayFemalemedicine.symptombusinessBiomarkersJournal of Hepatology
researchProduct

A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score

2020

Abstract Background We aimed at constructing a composite score based on Epstein-Barr virus DNAemia (EBVd) and simple clinical and immunological parameters to predict late severe infection (LI) beyond month 6 in solid organ transplantation (SOT) recipients. Methods Kidney and liver transplant recipients between May 2014 and August 2016 at 4 participating centers were included. Serum immunoglobulins and complement factors, peripheral blood lymphocyte subpopulations, and whole blood EBVd were determined at months 1, 3, and 6. Cox regression analyses were performed to generate a weighted score for the prediction of LI. Results Overall, 309 SOT recipients were followed-up for a median of 1000 da…

AdultMaleEpstein-Barr Virus InfectionsHerpesvirus 4 Humanmedicine.medical_specialtymedicine.medical_treatmentCD8-Positive T-LymphocytesOpportunistic Infections030230 surgeryLiver transplantationOrgan transplantationLeukocyte Count03 medical and health sciencesPostoperative Complications0302 clinical medicineInterquartile rangeInternal medicinemedicineHumansImmunology and AllergyAgedImmunosuppression TherapyReceiver operating characteristicProportional hazards modelbusiness.industryOrgan TransplantationMiddle AgedConfidence intervalTransplantationInfectious DiseasesROC CurvePeripheral blood lymphocyteDNA ViralMultivariate AnalysisFemale030211 gastroenterology & hepatologybusinessThe Journal of Infectious Diseases
researchProduct

Adrenal morphology and function in acromegalic patients in relation to disease activity.

2009

Visceromegaly is a common consequence of acromegaly. However, few studies investigated the chronic effects of growth hormone on adrenal glands. Our aim was to evaluate adrenal morphology and function in a cohort of acromegalic patients in relation to disease activity. Twenty-six acromegalics (10 males and 16 females) and 21 healthy subjects were investigated. Gland morphology was evaluated by computerized axial tomography, measuring central, lateral, and medial adrenal segments. Uncontrolled acromegalics showed increased volume of all adrenal segments, higher urinary free cortisol (UFC), and lower morning adrenocorticotropic hormone in comparison with healthy subjects. However, normal corti…

AdultMaleHypothalamo-Hypophyseal Systemmedicine.medical_specialtyEndocrinology Diabetes and MetabolismPituitary-Adrenal SystemAdrenocorticotropic hormoneCardiovascular SystemSeverity of Illness IndexSettore MED/13 - EndocrinologiaEndocrinologyDiabetes mellitusInternal medicineAdrenal GlandsAcromegalymedicineHumansAgedMorningbusiness.industryAdrenal glandCase-control studyOrgan SizeMiddle Agedmedicine.diseaseEndocrinologymedicine.anatomical_structureAcromegaly Growth hormone Adrenal gland CortisolCase-Control StudiesDexamethasone suppression testAcromegalyDisease ProgressionFemalebusinessVisceromegaly
researchProduct